The cyclic AMP cascade is altered in the fragile X nervous system
about
Synaptic Plasticity, a Prominent Contributor to the Anxiety in Fragile X SyndromeEmerging pharmacologic treatment options for fragile X syndromeFragile X syndrome and targeted treatment trials.Enhanced expression of ADCY1 underlies aberrant neuronal signalling and behaviour in a syndromic autism model.Epac2-mediated dendritic spine remodeling: implications for disease.Fragile X mental retardation protein is required for programmed cell death and clearance of developmentally-transient peptidergic neurons.4-Phenylbutyrate attenuates the ER stress response and cyclic AMP accumulation in DYT1 dystonia cell models.Increased long-term potentiation at medial-perforant path-dentate granule cell synapses induced by selective inhibition of histone deacetylase 3 requires Fragile X mental retardation proteinFruit flies and intellectual disability.Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment.PDE-4 inhibition rescues aberrant synaptic plasticity in Drosophila and mouse models of fragile X syndromeProteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotypeQuantitative profiling of brain lipid raft proteome in a mouse model of fragile X syndromeGlycogen synthase kinase-3: a promising therapeutic target for fragile x syndromeTargeted treatments for fragile X syndrome.Fetal alcohol spectrum disorders and abnormal neuronal plasticity.Cognitive Enhancement in Infants Associated with Increased Maternal Fruit Intake During Pregnancy: Results from a Birth Cohort Study with Validation in an Animal Model.Multiple Drug Treatments That Increase cAMP Signaling Restore Long-Term Memory and Aberrant Signaling in Fragile X Syndrome Models.The cyclic AMP phenotype of fragile X and autismThe translation of translational control by FMRP: therapeutic targets for FXS.Lovastatin corrects ERK pathway hyperactivation in fragile X syndrome: potential of platelet's signaling cascades as new outcome measures in clinical trials.GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model.Cilostazol strengthens barrier integrity in brain endothelial cells.Prenatal exposure to β2-adrenoreceptor agonists and the risk of autism spectrum disorders in offspring.Developing BACE-1 inhibitors for FXS.Cell-Type-Specific Translation Profiling Reveals a Novel Strategy for Treating Fragile X Syndrome.G-protein-associated signal transduction processes are restored after postweaning environmental enrichment in Ts65Dn, a Down syndrome mouse model.Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D).Fragile X Mental Retardation Protein Regulates Activity-Dependent Membrane Trafficking and Trans-Synaptic Signaling Mediating Synaptic Remodeling.Dampened dopamine-mediated neuromodulation in prefrontal cortex of fragile X mice.Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome.Activation of Serotonin 5-HT Receptors Modulates Hippocampal Synaptic Plasticity by Stimulation of Adenylate Cyclases and Rescues Learning and Behavior in a Mouse Model of Fragile X SyndromeStress Odorant Sensory Response Dysfunction in Fragile X Syndrome Mutants
P2860
Q26745117-95BD4DFA-ADFA-4124-A8F4-98E6FC8E13A8Q26829152-BA5CB832-80AA-4638-898A-EFFDEE259748Q26865162-CD52B91D-FD70-434B-BCF5-3AEAD6801907Q30362378-80279A33-FA37-4FA3-BEA0-88711D17B02BQ30471048-3B639E35-E360-497A-A654-67ACAEA70AAAQ30502814-CAE04363-994A-4ECA-B39C-993195B0F745Q34472800-C23BB0CA-0344-413E-81B6-32A80E43CFD5Q34563831-EF0FCDA3-1408-4973-956A-5566BE5235D2Q34610614-95B81D98-16A0-4D61-A3E8-7FDD4AA76977Q34631614-B7A9EE32-59B9-45BF-85CE-A8427FF26BC1Q34869830-2209D1CC-8D4E-4835-BF83-AC62EC51CA8CQ35111093-901F926F-604F-4CB5-B3F2-3BF2869A48CCQ35302189-82094117-ADF3-4D9C-B87F-B6E89B87B726Q35492486-50F4A93E-2DAE-424B-9A56-53C4AB386FA2Q35680726-A1D1C010-254C-4658-BD85-754333A12A62Q35915502-89CF4AA0-B199-443E-B6AA-2AA37EA126DDQ37034641-5E0F3006-9000-4ED9-BEEC-D1421650335EQ37054398-9EC12C79-609F-4B39-9997-E618C1758D36Q37097136-55E49EF8-FD76-4D83-98AD-B2FF463C8C26Q38098906-FFE2F232-665B-49F0-A1BD-3D98CE019C81Q38779847-293A383E-E027-4523-9A19-3ED845716425Q38787519-5A572308-28A8-4D50-B2B0-6895AFC42E1EQ39229705-44A95A2C-5F45-4141-94D5-3EF2025EAEA6Q40236964-EE770DCE-E968-4B56-8EA1-99D3E2FEE1F2Q41073215-935EF584-5B0B-49BC-93D2-193CF9453A6CQ41312671-DA100193-318C-4D94-88AE-02B6E0D6DC46Q42493391-A708FF91-9D66-4909-934B-D2F8B1FBAC9DQ47118227-D9BB076E-58C0-40CD-8419-E39C52B182B5Q47551369-E0B5522A-FDF5-459E-9329-0306975AE175Q48297462-E45E15EC-31AB-485B-8875-8B5D3FD8216FQ50307674-4C8485DD-C7A1-4B5F-9CFB-708035AD536DQ58586702-2C316AD2-9460-42EC-817C-270ED38FDFBFQ58795506-421D7E86-7FB7-4B9B-8655-4360D285EA9D
P2860
The cyclic AMP cascade is altered in the fragile X nervous system
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The cyclic AMP cascade is altered in the fragile X nervous system
@ast
The cyclic AMP cascade is altered in the fragile X nervous system
@en
The cyclic AMP cascade is altered in the fragile X nervous system.
@nl
type
label
The cyclic AMP cascade is altered in the fragile X nervous system
@ast
The cyclic AMP cascade is altered in the fragile X nervous system
@en
The cyclic AMP cascade is altered in the fragile X nervous system.
@nl
prefLabel
The cyclic AMP cascade is altered in the fragile X nervous system
@ast
The cyclic AMP cascade is altered in the fragile X nervous system
@en
The cyclic AMP cascade is altered in the fragile X nervous system.
@nl
P2093
P2860
P50
P1433
P1476
The cyclic AMP cascade is altered in the fragile X nervous system
@en
P2093
Daniel J Kelley
Jamie L Elliott
Jerry C P Yin
P2860
P356
10.1371/JOURNAL.PONE.0000931
P407
P577
2007-09-26T00:00:00Z